Pharma & Biotech

The telehealth sector faces renewed scrutiny as Hims & Hers Health finds itself in the crosshairs of US regulators. A...

KalVista Pharmaceuticals finds itself navigating conflicting market currents following the announcement of a significant capital raise. The biotech firm secured...

A remarkable case study from Germany, demonstrating a successful treatment for a severe form of ulcerative colitis, is fueling a...

Shares of gene-editing specialist Intellia Therapeutics have experienced significant momentum, driven by a major late-stage clinical development achievement. Investor enthusiasm...

As the patent protection for its blockbuster drug Jakafi approaches expiration, biopharmaceutical firm Incyte is implementing a two-pronged strategy to...

Shares of Viking Therapeutics experienced a notable upswing this week, climbing 7.4% on Wednesday to close at $26.82. The catalyst...

In a trading session characterized by broad market weakness, Mirati Therapeutics shares demonstrated exceptional resilience. The stock held completely flat,...

As markets experienced volatility in September, heavyweight investors demonstrated significant conviction in Vertex Pharmaceuticals. Both institutional players and corporate insiders...

Idorsia Ltd. shares are under significant selling pressure in the current trading session, continuing a pattern of high volatility. The...

Redcare Pharmacy shares are trading near their 52-week low, having shed more than 40% of their value since the start...